• News
  • Clinical
  • Professional
  • Students
  • Opinion
  • COVID-19
No Result
View All Result
No Result
View All Result
Home Opinion

‘Less than a year to develop a COVID vaccine – here’s why you shouldn’t be alarmed’

The vaccine trials have been nothing short of a miracle.

Share  
Tweet  
by Dr Mark Toshner
08/12/2020

Shutterstock

The word that keeps popping up is “rushed”.

I’m a clinical trials geek. I keep hearing people talk about the seven to ten years it takes to make a vaccine and how dangerous speeding this up might be. The word that keeps popping up is “rushed”, and it is making the average person nervous about vaccine safety. So, as a clinical trials doctor, I am going to tell you what I do for most of those ten years – and it is not very much.

I’m not lazy. I submit grants, have them rejected, resubmit them, wait for review, resubmit them somewhere else, sometimes in a loop of doom. When I am lucky enough to get trials funded, I then spend months on submitting to ethics boards. I wait for regulators, deal with personnel changes at the drugs company and a “change of focus” away from my trials, and eventually, if I am very lucky, I spend time setting up trials: finding sites, training sites, panicking because recruitment is poor, finding more sites. I then usually have more regulatory issues and, finally, if my big pot of luck is not used up, I might have a viable therapy – or not.

At this point, it might get delayed because of questions over profitability or any number of other obstacles. I’m not even going to go into the years it normally takes to get the “preclinical” studies, the ones before the human trials, done.

Ten years to develop a vaccine is a bad thing

So next time somebody expresses concern at the astonishing speed the vaccine trials have happened at, point out to them that ten years isn’t a good thing, it’s a bad thing. It’s not ten years because that is safe, it’s ten hard years of battling indifference, commercial imperatives, luck and red tape. It represents barriers in the process that we have now proved are “easy” to overcome. You just need unlimited cash, some clever and highly motivated people, all the world’s trial infrastructure, an almost unlimited pool of altruistic, wonderful trial volunteers and some sensible regulators.

With all of this and the clock ticking on a global pandemic killing people by the second, it turns out we can do amazing things. The vaccine trials have been nothing short of a miracle. A revolution in how we do trials that when you think about it is perhaps not that surprising given our ability to innovate when we really need to.

And we really need to – necessity being the mother of invention. Safety has not been compromised. All trials have been through the correct “phases” or process of any normal drug or vaccine. Hundreds of thousands of the very best of us volunteered and had an experimental vaccine. The world watched so closely that when a single person fell ill, we were all debating it.

To date, there has not been a single associated death related to COVID vaccines and only a handful of potentially serious events. Just imagine watching everybody in a small city for six months and reporting every single heart attack, stroke, neurological condition or anything that might be judged serious. How astonishing is this? It has been a triumph of medical science.

Turbocharged.

I haven’t even touched on the lucky confluence of timing that meant this all happened at a time when sequencing all the genes in a person or virus is so routine nobody bats an eyelid. This turbocharged the early preclinical science needed as the foundation stone of several new technologies at the right point to be exploited.

At this time, three vaccines have already broken cover and demonstrated efficacy higher than we had ever hoped. The bar was set by regulators at around 50%. Both Moderna and Pfizer reported 95% efficacy, and Oxford University reported 90% efficacy for a particular dosage regimen. Safety data is still to follow, but the track record of vaccines is excellent, and I am an optimist.

None of this is to downplay the challenges still ahead. It is also not to say vaccines are without safety questions still to be answered. It has been, however, a triumph of good process and great people. I am confident that when regulators pore over the safety and efficacy data, closely followed by every interested scientist in the world, that vaccines will only be used if their benefits clearly outweigh the risks – and you should be confident too.


Dr Mark Toshner, Director of Translational Biomedical Research, University of Cambridge. This article is republished from The Conversation under a Creative Commons license. Read the original article.

ADVERTISEMENT

POPULAR

Pfizer doses should be six weeks apart not twelve, say doctors

25/01/2021

Over 850 health and social care workers have now died of COVID-19

25/01/2021

RCN election policy needs to be modernised, finds report

26/01/2021

Over half a million people vaccinated against Coronavirus in under two weeks

29/12/2020

No plausible way the COVID-19 vaccine could impact women’s fertility, say RCOG and RCM

20/01/2021
ADVERTISEMENT
ADVERTISEMENT


the Handover

Nursing news and clinical updates direct to your inbox.



Your data is held in accordence with our Privacy Policy.

Related Posts

Workforce

NHS staff want ‘respite’ and ‘reinforcements’ more than a pay rise, claims NHS chief

27/01/2021
Workforce

Public overwhelmingly support a 10% pay rise for nursing staff, finds poll

26/01/2021
News

RCN election policy needs to be modernised, finds report

26/01/2021
News

Over 850 health and social care workers have now died of COVID-19

25/01/2021
Workforce

Pfizer doses should be six weeks apart not twelve, say doctors

25/01/2021
Workforce

RCN demands answers over PPE ‘postcode lottery’

23/01/2021
News

RCN sets new September date for face-to-face or virtual Congress

22/01/2021
Workforce

Medical students demand an end to ‘compulsory’ placements covering ‘menial’ nursing duties

21/01/2021
NursingNotes

NursingNotes has been created for nurses by nurses.

Follow Us

Top Categories

  • Clinical
  • Education
  • Health Politics
  • News
  • Opinion
  • Professional
  • Research
  • Resources
  • Sponsored
  • Workforce

Recent Posts

  • NHS staff want ‘respite’ and ‘reinforcements’ more than a pay rise, claims NHS chief
  • Public overwhelmingly support a 10% pay rise for nursing staff, finds poll
  • RCN election policy needs to be modernised, finds report
  • Over 850 health and social care workers have now died of COVID-19
  • Agenda for Change NHS Pay Bands
  • Privacy Policy
  • Terms of Service
  • About us
  • Contact us

© 2019 NursingNotes.co.uk

No Result
View All Result
  • News
  • Clinical
  • Professional
  • Students
  • Opinion
  • COVID-19

© 2019 NursingNotes.co.uk

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.